Paragraph 169 I1
United Kingdom
In regulation 213 (amendment of regulation 281 (duties of authorisation holders and registration holders)) for paragraphs (b) and (c) substitute—
“(b)omit “or” at the end of sub-paragraph (c); and
(c)in sub-paragraph (d), after “for a medicinal product” insert—
“; or
(e)an EU marketing authorisation for a medicinal product.”.”.
Annotations
Commencement
- I1
Sch. 2 para. 169 in force at 31.12.2020 immediately before IP completion day, see reg. 1